Partner Content
How serialization will shape the future of the pharma industry
Q: What are the key challenges facing the pharmaceutical industry when it comes to implementing serialization regulations?From a technological standpoint,…
How CATs can enhance clinical trials
PROMs are composed of a fixed number of items – that is, a question and its associated response scale. While…
Outsourcing trends in clinical trials: How one company is reimagining the FSP model
Full-service outsourcing has traditionally ruled the roost in the clinical world, but increased competition from functional service providers (FSPs) has…
Host-Cell Protein Analytics: History and Future Trends
Different analytical methods have been developed to detect host-cell proteins (HCPs) in bioprocess streams. Advancements in such methods are enabling…
No more cookies: How healthcare companies can gain trust for data consent
Data is a valuable commodity in an age of data-driven marketing, but considerable care must be taken when collecting sensitive…
Improving health equity in Europe’s small countries: How can we remove the barriers to access?
When it comes to health equity, the citizens of smaller countries in Europe can sometimes be at a disadvantage. According…
Launching pharmaceuticals in the Nordics: Opportunities and challenges
The Nordic countries have it all. From beautiful landscapes lit by the northern lights to world-class living standards and generous…
Clinical trials: How AI can help providers stay TMF inspection-ready
The clinical trials landscape is evolving quickly. Delivery of clinical research has changed as the industry has faced myriad challenges,…
Does AI/ML make CROs obsolete? It depends…
One of the many luxuries of working in an industry for a long time is that you get to witness…
How a flexible FSP model fills the talent gap
There is continuous evaluation and varying opinion regarding the strategic resourcing models employed within the biopharmaceutical sector today. Notwithstanding the…